COST-EFFECTIVENESS OF GLYCOPYRRONIUM / INDACATEROL COMBINATION VS. SALMETEROL/FLUTICASONE (FIXED DOSE COMBINATION - CDF) IN THE MANAGEMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (EPOC) IN COLOMBIA (SOUTH AMERICA)

被引：0
|
作者：
Karpf, E. [1 ]
Londono, D. [2 ]
Olaya, A. [1 ]
机构：
[1] Novartis Colombia, Bogota, DC, Colombia
[2] Fdn Santa Fe Bogota, Salud Publ, Bogota, DC, Colombia
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.372
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRS10
引用
收藏
页码：A840 / A840
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS ANALYSIS OF THE FIXED COMBINATION INDACATEROL/GLYCOPYRRONIUM VS. TIOTROPIUM AND SALMETEROL/FLUTICASONE IN THE MANAGEMENT OF COPD IN GREECE
    Geitona, M.
    Kousoulakou, H.
    Kalogeropoulou, M.
    Mitsiki, E.
    Panitti, E.
    Steiropoulos, P.
    VALUE IN HEALTH, 2015, 18 (07) : A500 - A500
  • [2] Cost-effectiveness of indacaterol/glycopyrronium in comparison with salmeterol/fluticasone combination for patients with moderate-to-severe chronic obstructive pulmonary disease: a LANTERN population analysis from Singapore
    Tee, Augustine
    Chow, Wai Leng
    Burke, Colin
    Guruprasad, Basavarajaiah
    SINGAPORE MEDICAL JOURNAL, 2018, 59 (07) : 383 - 389
  • [3] Cost-effectiveness of Salmeterol/Fluticasone Combination Therapy vs. Fluticasone Propionate in Japanese Asthmatic Patients
    Tohda, Yuji
    Nishima, Sankei
    Arakawa, Ichiro
    Shiragami, Makoto
    Miyamoto, Terumasa
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2010, 130 (04): : 593 - 603
  • [4] COST-EFFECTIVENESS OF INDACATEROL/GLYCOPYRRONIUM IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN BRAZIL
    Tozato, C.
    Suzuki, C.
    VALUE IN HEALTH, 2018, 21 : S411 - S411
  • [5] Evaluation Of Cost-Effectiveness Of Glycopyrronium Vs. Tiotropium In The Management Of Chronic Obstructive Pulmonary Disease In Taiwan
    Chan, M. -C.
    Lin, T. -C.
    Yang, Y. Kao
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [6] Cost-effectiveness analysis of a fixed-dose combination of indacaterol and glycopyrronium as maintenance treatment for COPD
    Chan, Ming-Cheng
    Tan, Elise Chia-Hui
    Yang, Ming-Chin
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 : 1079 - 1088
  • [7] Low-dose Fluticasone Propionate in Combination With Salmeterol in Patients With Chronic Obstructive Pulmonary Disease
    Yasui, Hideki
    Inui, Naoki
    Fujisawa, Tomoyuki
    Karayama, Masato
    Enomoto, Noriyuki
    Nakamura, Yutaro
    Kuroishi, Shigeki
    Ohba, Hisano
    Yokomura, Koshi
    Sato, Jun
    Sato, Masaki
    Koshimizu, Naoki
    Toyoshima, Mikio
    Yamada, Takashi
    Masuda, Masafumi
    Shirai, Toshihiro
    Suda, Takafumi
    CLINICAL MEDICINE INSIGHTS-CIRCULATORY RESPIRATORY AND PULMONARY MEDICINE, 2018, 12
  • [8] AN ECONOMIC EVALUATION OF INDACATEROL/GLYCOPYRRONIUM COMPARED WITH TIOTROPIUM AND SALMETEROL/FLUTICASONE FOR PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN THAILAND
    Boonsawat, W.
    Geater, S. L.
    Burke, C.
    Numuang, K.
    RESPIROLOGY, 2016, 21 : 180 - 180
  • [9] QVA149 (Indacaterol/Glycopyrronium Fixed-Dose Combination): A Review of Its Use in Patients with Chronic Obstructive Pulmonary Disease
    Frampton, James E.
    DRUGS, 2014, 74 (04) : 465 - 488
  • [10] QVA149 (Indacaterol/Glycopyrronium Fixed-Dose Combination): A Review of Its Use in Patients with Chronic Obstructive Pulmonary Disease
    James E. Frampton
    Drugs, 2014, 74 : 465 - 488
12345